Sirona Biochem (Seite 1491)
eröffnet am 23.06.13 12:55:10 von
neuester Beitrag 30.04.24 15:18:17 von
neuester Beitrag 30.04.24 15:18:17 von
Beiträge: 31.028
ID: 1.183.167
ID: 1.183.167
Aufrufe heute: 180
Gesamt: 5.401.469
Gesamt: 5.401.469
Aktive User: 0
ISIN: CA82967M1005 · WKN: A0RM6R · Symbol: ZSB
0,0465
EUR
+6,90 %
+0,0030 EUR
Letzter Kurs 17:53:55 Tradegate
Neuigkeiten
08.04.24 · globenewswire  |
05.04.24 · globenewswire |
28.03.24 · globenewswire |
13.03.24 · globenewswire |
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 3,6700 | +90,16 | |
| 2,0500 | +64,00 | |
| 1,2099 | +34,52 | |
| 1,7000 | +33,86 | |
| 0,9500 | +33,67 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 6,0500 | -14,06 | |
| 1,2029 | -14,15 | |
| 1,6100 | -15,26 | |
| 3,5000 | -26,24 | |
| 11,500 | -29,23 |
Beitrag zu dieser Diskussion schreiben
Feedback
Allein nachfolgende Punkte dürften eigentlich ein Gelingen dick unterstreichen und es geht nicht nur um Hautaufheller bei R&F:
- Howard Verrico & Géraldine Deliencourt-Godefroy besitzen unendlich viele Aktien - die wissen warum
- NA-Deal mit Ausdehnung auf Japan:
R&F Due Diligence 1 Jahr erfolgreich angekündigt, 20 kg TFC-1067, Patente
- China-Deal: Chinesen haben viele Aktien gekauft
und Rechtsanwalt Jason Tian wurde Director & hat sehr viele Aktien selbst bei ca. 0,3 Euro gekauft
- Weiteres: Antidiabetic (Human, Cats & Dogs), Anti-lipid (Antifalten),
Proteinstabilisation für viele medizinische Produkte (extrem wichtig und riesiges Gebiet)
Wer ist aber jetzt nicht aufgeregt? Ganz normal ...
Fällt nur schwerer sich auf Arbeit zu konzentrieren
Aber seit 2015 Üben des Wartens, fällt das weniger schwer
Wenn der Kurs sich - wie gestern - nach unten biegt, löst das Angst aus.
Da die Fakten für sich sprechen und so positiv sind, sollten wir longs uns auf keinen Fall zum Verkauf drängen lassen.
Allen viel Glück
- Howard Verrico & Géraldine Deliencourt-Godefroy besitzen unendlich viele Aktien - die wissen warum
- NA-Deal mit Ausdehnung auf Japan:
R&F Due Diligence 1 Jahr erfolgreich angekündigt, 20 kg TFC-1067, Patente
- China-Deal: Chinesen haben viele Aktien gekauft
und Rechtsanwalt Jason Tian wurde Director & hat sehr viele Aktien selbst bei ca. 0,3 Euro gekauft
- Weiteres: Antidiabetic (Human, Cats & Dogs), Anti-lipid (Antifalten),
Proteinstabilisation für viele medizinische Produkte (extrem wichtig und riesiges Gebiet)
Wer ist aber jetzt nicht aufgeregt? Ganz normal ...
Fällt nur schwerer sich auf Arbeit zu konzentrieren
Aber seit 2015 Üben des Wartens, fällt das weniger schwer
Wenn der Kurs sich - wie gestern - nach unten biegt, löst das Angst aus.
Da die Fakten für sich sprechen und so positiv sind, sollten wir longs uns auf keinen Fall zum Verkauf drängen lassen.
Allen viel Glück
... mittwoch !!!
ORIGINAL: Sirona Biochem Signs Definitive License & Supply Agreement with Skincare Industry Leader Rodan + Fields
2019-09-18 03:00 ET - News Release
Sirona Biochem Signs Definitive License & Supply Agreement with Skincare Industry Leader Rodan + Fields
Canada NewsWire
VANCOUVER, Sept. 18, 2019
VANCOUVER, Sept. 18, 2019 /CNW/ - Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) ("Sirona") is excited to announce that it has completed a definitive agreement with Rodan + Fields, LLC ("Rodan + Fields"), the leading skin care brand in the United States1, for the licensing and commercial sales of novel ingredient TFC-1067 to brighten and even skin tone. Rodan and Fields will be the first to market for a consumer product utilizing TFC-1067 in certain countries including United States.
Under the terms of the agreement, Sirona will receive an upfront and milestone payments as well as on-going revenue in return for the manufacture and supply of TFC-1067, a novel, new skin brightening ingredient, for use by Rodan + Fields on a non-exclusive basis and Rodan + Fields will launch a new product incorporating the ingredient. Further details of this agreement will remain confidential for strategic reasons. Both Sirona and Rodan + Fields look forward to a mutually beneficial long-term relationship.
"Sirona's board concluded that working on a non-exclusive basis will enable us to advance, in parallel, on multiple global partnerships. We are therefore continuing active partnering discussions regarding TFC-1067. Ultimately, we will achieve maximum commercial value by penetrating the numerous sales channels and territories available. This will enable us to capture a larger portion of the global skin lightening market with TFC-1067", reports Dr. Howard Verrico, CEO of Sirona Biochem.
The agreement also establishes regular meetings between Sirona's and Rodan + Field's scientists to explore future collaborations on new consumer products. This brings together the full spectrum of expertise to take early stage concept through to an innovative formulated product worthy of the Rodan + Fields skin care philosophy.
Contract Research Organization (CRO) Roowin (www.roowin.com) has developed a chemical process required for large scale manufacturing of TFC-1067 and has now been instructed by Sirona to begin manufacturing to fill anticipated orders for the product launch.
"The commercial validation of our platform technology represents a major milestone for Sirona's team. This agreement marks a first step in the introduction of TFC-1067 into key markets and the launch of TFC-1067 into the global market", added Dr. Verrico. "We have worked through extensive due diligence and built a good relationship with Rodan + Fields. We are very pleased to be working with the number one skincare brand in the U.S.2 for the launch of our innovative and superior skin brightening compound, TFC-1067. Moreover, we are looking forward to update our shareholders about our progress in China in due course."
"As a company committed to innovation, Rodan + Fields continually seeks out novel and ground-breaking technologies. We're excited to partner with Sirona to commercialize this highly novel new molecule in an up-and-coming product release and deliver the well-validated benefits to our consumer base", said Dr. Simon Craw, Senior Director R&D Business Development at Rodan + Fields. "Developing long-term strategic relationships with biotech companies is part of Rodan + Fields' DNA, and in Sirona we see an innovation-focused company we can work closely with over the next several years", Dr Craw continued.
About Rodan + Fields
Founded by Stanford-trained dermatologists Dr. Katie Rodan and Dr. Kathy Fields, Rodan + Fields was launched in 2002 with the mission of giving consumers the best skin of their lives. The brand is a result of the Doctors' belief that healthy skin empowers people to feel confident. Born in the digital era and designed to directly reach consumers where they live and shop via mobile and social networks, Rodan + Fields is disrupting the industry with its regimen-based skincare and powerful Independent Consultant community.
For more information, please visit www.rodanandfields.com.
________________________
1
Source Euromonitor International Limited; Beauty and Personal Care 2019 Edition, retail value RSP terms; all channels, Skincare includes Sets & Kits
2
Source Euromonitor International Limited; Beauty and Personal Care 2019 Edition, retail value RSP terms; all channels, Skincare includes Sets & Kits
About Sirona Biochem Corp.
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.
Sirona's compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona's laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants. For more information, please visit www.sironabiochem.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
S
2019-09-18 03:00 ET - News Release
Sirona Biochem Signs Definitive License & Supply Agreement with Skincare Industry Leader Rodan + Fields
Canada NewsWire
VANCOUVER, Sept. 18, 2019
VANCOUVER, Sept. 18, 2019 /CNW/ - Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) ("Sirona") is excited to announce that it has completed a definitive agreement with Rodan + Fields, LLC ("Rodan + Fields"), the leading skin care brand in the United States1, for the licensing and commercial sales of novel ingredient TFC-1067 to brighten and even skin tone. Rodan and Fields will be the first to market for a consumer product utilizing TFC-1067 in certain countries including United States.
Under the terms of the agreement, Sirona will receive an upfront and milestone payments as well as on-going revenue in return for the manufacture and supply of TFC-1067, a novel, new skin brightening ingredient, for use by Rodan + Fields on a non-exclusive basis and Rodan + Fields will launch a new product incorporating the ingredient. Further details of this agreement will remain confidential for strategic reasons. Both Sirona and Rodan + Fields look forward to a mutually beneficial long-term relationship.
"Sirona's board concluded that working on a non-exclusive basis will enable us to advance, in parallel, on multiple global partnerships. We are therefore continuing active partnering discussions regarding TFC-1067. Ultimately, we will achieve maximum commercial value by penetrating the numerous sales channels and territories available. This will enable us to capture a larger portion of the global skin lightening market with TFC-1067", reports Dr. Howard Verrico, CEO of Sirona Biochem.
The agreement also establishes regular meetings between Sirona's and Rodan + Field's scientists to explore future collaborations on new consumer products. This brings together the full spectrum of expertise to take early stage concept through to an innovative formulated product worthy of the Rodan + Fields skin care philosophy.
Contract Research Organization (CRO) Roowin (www.roowin.com) has developed a chemical process required for large scale manufacturing of TFC-1067 and has now been instructed by Sirona to begin manufacturing to fill anticipated orders for the product launch.
"The commercial validation of our platform technology represents a major milestone for Sirona's team. This agreement marks a first step in the introduction of TFC-1067 into key markets and the launch of TFC-1067 into the global market", added Dr. Verrico. "We have worked through extensive due diligence and built a good relationship with Rodan + Fields. We are very pleased to be working with the number one skincare brand in the U.S.2 for the launch of our innovative and superior skin brightening compound, TFC-1067. Moreover, we are looking forward to update our shareholders about our progress in China in due course."
"As a company committed to innovation, Rodan + Fields continually seeks out novel and ground-breaking technologies. We're excited to partner with Sirona to commercialize this highly novel new molecule in an up-and-coming product release and deliver the well-validated benefits to our consumer base", said Dr. Simon Craw, Senior Director R&D Business Development at Rodan + Fields. "Developing long-term strategic relationships with biotech companies is part of Rodan + Fields' DNA, and in Sirona we see an innovation-focused company we can work closely with over the next several years", Dr Craw continued.
About Rodan + Fields
Founded by Stanford-trained dermatologists Dr. Katie Rodan and Dr. Kathy Fields, Rodan + Fields was launched in 2002 with the mission of giving consumers the best skin of their lives. The brand is a result of the Doctors' belief that healthy skin empowers people to feel confident. Born in the digital era and designed to directly reach consumers where they live and shop via mobile and social networks, Rodan + Fields is disrupting the industry with its regimen-based skincare and powerful Independent Consultant community.
For more information, please visit www.rodanandfields.com.
________________________
1
Source Euromonitor International Limited; Beauty and Personal Care 2019 Edition, retail value RSP terms; all channels, Skincare includes Sets & Kits
2
Source Euromonitor International Limited; Beauty and Personal Care 2019 Edition, retail value RSP terms; all channels, Skincare includes Sets & Kits
About Sirona Biochem Corp.
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.
Sirona's compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona's laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants. For more information, please visit www.sironabiochem.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
S
Sirona Biochem Signs Definitive License & Supply Agreement with Skincare Industry Leader Rodan + Fields
https://ceo.ca/@newswire/sirona-biochem-signs-definitive-lic…
https://ceo.ca/@newswire/sirona-biochem-signs-definitive-lic…
Antwort auf Beitrag Nr.: 61.507.298 von sirlacoura am 18.09.19 08:10:19Es muß ja nicht immer einen Tag vor den News gekauft werden, was das Konto her gibt.
Die Freunde undd Bekannten der Insider und Mitarbeiter wissen von diesem Deal bestimmt schon seit längerem, die könnten sich schon längst eingedeckt haben.
Die Freunde undd Bekannten der Insider und Mitarbeiter wissen von diesem Deal bestimmt schon seit längerem, die könnten sich schon längst eingedeckt haben.
Trading Spotlight
Antwort auf Beitrag Nr.: 61.507.565 von grounding am 18.09.19 08:34:11
so lange am Freitagabend nach 22h nichts kommt, ist es okay 🤭
Zitat von grounding:Zitat von Ulfred: Und heute soll also mal wieder der große Tag sein...?
Heute, nächste Woche?
Viele Mittwochs gibts in diesem Quartal nicht mehr 😂.
so lange am Freitagabend nach 22h nichts kommt, ist es okay 🤭
Antwort auf Beitrag Nr.: 61.507.547 von Ulfred am 18.09.19 08:32:04
Heute, nächste Woche?
Viele Mittwochs gibts in diesem Quartal nicht mehr 😂.
Zitat von Ulfred: Und heute soll also mal wieder der große Tag sein...?
Heute, nächste Woche?
Viele Mittwochs gibts in diesem Quartal nicht mehr 😂.
Und heute soll also mal wieder der große Tag sein...?
Antwort auf Beitrag Nr.: 61.506.485 von shaxx am 17.09.19 23:24:40Ach was, es ist ja ohnehin bekannt, dass Sirona und R+F zusammenpannen werden (oder wollen), das ist ja kein Geheimnis. Und ich wette mit Dir, dass 99.9% der Damen, die diese R+F Produkte verticken, noch nie was von Sirona gehört haben und es sie auch in Zukunft nicht interessiert. Da geht's einfach darum, dass die gute Produkte an die Frau bringen können. Wer da dann was zuliefert, das interessiert nicht. Überschätzt weder R+F noch Sirona und Vergleiche mit Apple und der Key Notes ist ja dann auch sehr weit hergeholt
Antwort auf Beitrag Nr.: 61.507.298 von sirlacoura am 18.09.19 08:10:19
Möglicherweise kommt wie von vielen erahnt noch nichts!
Schön wärs, spielt aber eigentlich auch keine Rolle. Hauptsache positiv müssen die News sein, unabhängig von Datum und Zeit 😊.
Wir werden es genug früh erkennen, wenn die Party abgeht 😎!
Vielleicht bereits heute um 09.00 Uhr oder auch nicht.
Ich halte sowieso ALLES.
good luck @all
Zitat von sirlacoura: Was mich bei aller Euphorie etwas stutzig macht ist, dass diese Woche kein wirklicher Druck auf den Kessel kam. Was ansich ungewöhnlich ist, da der Kurs immer vorher reagiert hat, wenn News anstanden. Hoffen wir das Beste.
Möglicherweise kommt wie von vielen erahnt noch nichts!
Schön wärs, spielt aber eigentlich auch keine Rolle. Hauptsache positiv müssen die News sein, unabhängig von Datum und Zeit 😊.
Wir werden es genug früh erkennen, wenn die Party abgeht 😎!
Vielleicht bereits heute um 09.00 Uhr oder auch nicht.
Ich halte sowieso ALLES.
good luck @all
Durchsuchen
